DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc., a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, ...
BERKELEY, Calif, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology ...
The head of the Sierra Gold Nurseries’ Quality Control Lab talks tissue culture. At Indoor Ag-Con, Stevens is part of a panel ...
– Positive responses from surgeons and trauma centers to initial sales and marketing outreach – To communicate the health economic value of Symvess, Humacyte has developed a Budget Impact Model (BIM) ...
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR BERKELEY ...
DURHAM, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results